摘要
目的探讨血清降钙素原(PCT)在重症肺炎诊断中的临床意义。方法选择40例重症肺炎患者(第一组)、35例轻型肺炎患者(第二组)、35名健康的体检者(第三组)作为研究对象,对比分析血清降钙素原以及预后等指标。结果 PCT值第一组(6.01±7.12)ng/mL,第二组(0.81±0.72)ng/mL,第三组(0.12±0.11)ng/mL。结论血清降钙素原能反映肺炎患者的严重程度,并能作为判断预后的重要指标。
Objective To investigate the clinical significance of serum procalcitonln (PCT)in the diagnosis ot severe pneumonia. Methods Choose 40 cases of patients with severe pneumonia (group 1), 35 cases of mild pneumonia patients (group second), 35 cases of healthy subjects (Group Third) as the object of study, compare the serum procalcitonin and prognosis index in both groups. Results PCT values in the first group (6.01±7.12) ng/mL, second groups (0.81±0.72)ng/mL, third groups (0.12 ±0.11)ng/mL. Conclusion The level of serum procalcitonin can reflect the severity of pneumonia patients, and can be used as an important index of judging prognosis.
出处
《中国卫生产业》
2013年第24期15-15,17,共2页
China Health Industry
关键词
重症肺炎
血清降钙素原
诊断意义
Severe pneumonia
Procalcitonin
Diagnostic significance